Utility of an in-office C6 ELISA test kit for determination of infection status of dogs naturally exposed to Borrelia burgdorferi

Veterinary Therapeutics

Volumn 3, Issue 3, 2002, Pages

  Levy, Steven ^a   O'Connor, Thomas ^a   Hanscom, Jancy ^a   Shields, Paulette ^a  

^a IDEXX LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA; BORRELIA BURGDORFERI; CANIS FAMILIARIS; DIROFILARIA IMMITIS; EHRLICHIA CANIS;

EID: 79251490122     PISSN: 15283593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Grauer GF, Burgess EC, Cooley AJ, et al: Renal lesions associated with Borrelia burgdorferi infection in a dog. JAVMA 193:237-239, 1988.
2. Kornblatt AN, Urband PH, Steere AC: Arthritis caused by Borrelia burgdorferi in dogs. JAVMA 186:960-964, 1985.
3. Levy SA: Lyme disease. Standards of Care 3:1-6, 2001.
4. Levy SA, Barthold SW, Domback DM, et al: Canine Lyme borreliosis. Compend Contin Educ Pract Vet 15:833-846, 1993.
5. Levy SA, Dreesen DW: Lyme borreliosis in dogs. Canine Pract 17:5-14, 1992.
6. Levy SA, Duray PH: Complete heart block in a dog seropositive for Borrelia burgdorferi. Similarity to human Lyme carditis. J Vet Intern Med 2:138-144, 1988.
7. Levy SA, Magnarelli LA: Relationship between development of antibodies to Borrelia burgdorferi in dogs and the subsequent development of limb/joint borreliosis. JAVMA 200:344-347, 1992.
8. Magnarelli LA, Anderson JF, Kaufmann AF, et al: Borreliosis in dogs from southern Connecticut. JAVMA 186:955-959, 1985.
9. Magnarelli LA, Anderson JF, Schreier AB, et al: Clinical and serological studies of canine borreliosis. JAVMA 191:1089-1094,1987.
10. Lissman BA, Bosler EM, Camay H, et al: Spirochete-associated arthritis (Lyme disease) in a dog. JAVMA 185:219-220, 1984.
11. Burgdorfer W, Barbour AG, Hayes SF, et al: Lyme disease-A tick-borne spirochetosis Science 216:1317-1319, 1982.
12. Steere AC, Grodzicki RL, Kornblatt AN: The spirochetal etiology of Lyme disease. N Eng J Med 308:733-739, 1983.
13. Wasmoen TL, Sebring RW, Blumer BM, et al: Examination of Koch's postulates for Borrelia burgdorferi as the causative agent of limb/joint dysfunction in dogs with borreliosis. JAVMA 201:412-418, 1992.
14. Burgess EC:. Natural exposure of Wisconsin dogs to the Lyme disease spirochete (Borrelia burgdorferi). Lab Anim Sci 36:288-290, 1986.
15. Appel MJG, Allan S, Jacobson RH, et al: Experimental Lyme disease in dogs produces arthritis and persistent infection. J Infect Dis 167:651-664, 1993.
16. Barthold SW, Levy SA, Fikrig E, et al: Serologic responses of dogs naturally exposed to or vaccinated against Borrelia burgdorferi infection. JAVMA 207:1435-1440, 1995.
17. Levy SA: Why I vaccinate dogs against infection with Lyme disease. Compend Contin Educ Pract Vet 19: 1268-1275, 1997.
18. Greene RT, Hirsch DA, Rottman PL, et al: Interlaboratory comparison of titers of antibody to Borrelia Burgdorferi and evaluation of a commercial assay using canine serum. J Clin Microbiol 29:16-20, 1991.
19. Greene RT: An update on the serodiagnosis of canine Lyme borreliosis. J Vet Intern Med 4:167-171, 1990.
20. Levy SA, Lissman BA, Ficke CM: Performance of a Borrelia burgdorferi bacterin in borreliosis-endemic areas. JAVMA 202:1834-1838, 1993.
21. Greene RT, Walker RL, Burgess EC, et al: Heterogeneity in immunoblot patterns obtained by using four strains of Borrelia burgdorferi and sera from naturally exposed dogs. J Clin Microbiol 26:2287-2291, 1988.
22. Greene RT, Walker RL, Nicholson WL, et al: Immunoblot analysis of innunoglobulin G response to the Lyme disease agent (Borrelia burgdorferi) in experimentally and naturally exposed dogs. J Clin Microbiol 26:648-653, 1988.
23. Magnarelli LA, Anderson JF, Schreier AB: Persistence of antibodies to Borrelia burgdorferi in dogs of New York and Connecticut. JAVMA 196:1064-1068, 1990.
24. Magnarelli LA, Levy SA, Ijdo JW, et al: Reactivity of dog sera to whole-cell or recombinant antigens of Borrelia burgdorferi by ELISA and immunoblot analysis. J Med Microbiol 50:889-895, 2001.
25. Guerra MA, Walker ED, Kitron U: Quantitative approach for the serodiagnosis of canine Lyme disease by the immunoblot procedure. J Clin Microbiol 38:2628-2632, 2000.
26. Chu H-J, Chavez LG, Blumer BM, et al: Immunogenicity and efficacy study of a commercial Borrelia burgdorferi bacterin. JAVMA 201:403-411, 1992.
27. Gauthier D, Mansfield L: Western immunoblot analysis for distinguishing vaccination and infection status with Borrelia burgdorferi (Lyme disease) in dogs. J Vet Diagn Invest 11:259-265, 1999.
28. Liang FT, Philipp MT: Epitope mapping of the immunodominant invariable region of Borrelia burgdorferi VlsE in three host species. Infect Immun 68:2349-2352, 2000.
29. Liang FT, Jacobson RH, Straubinger RK, et al: Characterization of a Borrelia burgdorferi VlsE invariable region useful in canine Lyme disease serodiagnosis by enzyme-linked immunosorbent assay. J Clin Microbiol 38:4160-4166, 2000.
30. Liang FT, Aberer E, Cinco M, et al: Antigenic conservation of an immunodominant invariable region of the VlsE lipoprotein among European pathogenic genospecies of Borrelia burgdorferi SL. J Infect Dis 182:1455-1462, 2000.
31. Liang FT, Bowers LC, Philipp MT: C-Terminal invariable region domain of VlsE is immunodominant but its antigenicity is scarcely conserved among strains of Lyme disease spirochetes. Infect Immun 69:3224-3231, 2001.
32. Liang FT, Steere AC, Marques AR, et al: Sensitive and specific serodiagnosis of Lyme disease by enzyme-linked immunosorbent assay with a peptide based on an immunodominant conserved region of Borrelia burgdorferi VlsE. J Clin Microbiol 37:3990-3996, 1999.
33. O'Connor TP, Esty KE, MacHenry P, et al: Performance evaluation of Ehrlichia canis and Borrelia burgdorferi peptides in a new Dirofilaria immitis combination assay. Proc 10th Triennial Symposium Amer Heartworm Soc, in press, 2002.
34. O'Connor TP, Esty KE, Hanscom JL, et al: Dogs vaccinated with common Lyme disease vaccines do not respond to IR , the conserved immunodominant region of the VlsE surface protein of Borrelia burgdorferi. J Clin Microbiol, submitted for publication, 2002.
35. Philipp MT, Bowers LC, Fawcett PT, et al: Antibody response to IR , a conserved immunodominant region of the VlsE lipoprotein, wanes rapidly after antibiotic treatment of Borrelia burgdorferi infection in experimental animals and humans. J Infect Dis 184:870-878, 2001.
36. Hashida S, Imagawa M, Inoue S, et al: More useful maleimide compounds for the conjugation of Fab' to horseradish peroxidase through the thiol groups in the hinge. J Appl Biochem 6:56-63, 1984.